{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:08:40Z","timestamp":1790615320461,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015303","name":"Otsuka Pharmaceutical Development and Commercialization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jad.2017.10.035","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T22:45:17Z","timestamp":1508798717000},"page":"649-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder"],"prefix":"10.1016","volume":"227","author":[{"given":"Joseph R.","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Amatniek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Such","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretta","family":"Nyilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.10.035_bib1","unstructured":"American Psychiatric Association, 2002. Practice Guideline for the Treatment of Patients with Bipolar Disorder, Second Edition. (Online). Available from: \u3008http:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/bipolar.pdf\u3009 (cited July 21, 2016)."},{"key":"10.1016\/j.jad.2017.10.035_bib2","first-page":"e1","article-title":"Correlates of medication adherence among patients with bipolar disorder: results of the Bipolar Evaluation of Satisfaction and Tolerability (BEST) study: a nationwide cross-sectional survey","volume":"12","author":"Bates","year":"2010","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/nedt.2006.2.2.149","article-title":"Bipolar disorders: treatment options and patient satisfaction","volume":"2","author":"Bowden","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2017.10.035_bib4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1176\/appi.ajp.2010.09101406","article-title":"Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder","volume":"167","author":"Bowie","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study","volume":"78","author":"Calabrese","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-5618.2004.00171.x","article-title":"Recovery and functional outcomes following olanzapine treatment for bipolar I mania","volume":"7","author":"Chengappa","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.15032su1","article-title":"The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence","volume":"77","author":"Correll","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4088\/JCP.14m09210","article-title":"Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study","volume":"77","author":"Deckersbach","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-5618.2005.00207.x","article-title":"Functional impairment in the remission phase of bipolar disorder","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2017.10.035_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/11631310-000000000-00000","article-title":"Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder","volume":"26","author":"Gigante","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2017.10.035_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.10.035_bib13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2017.10.035_bib14","series-title":"Clinical Global Impression Scale (CGI)","first-page":"217","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2017.10.035_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.euroneuro.2010.08.001","article-title":"2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery","volume":"21","author":"Haro","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.10.035_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2017.10.035_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3111\/13696998.2014.979936","article-title":"Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis","volume":"18","author":"Kane","year":"2015","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.jad.2017.10.035_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2008.05.013","article-title":"Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project","volume":"50","author":"Kauer-Sant'Anna","year":"2009","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib20","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-244X-13-340","article-title":"Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness","volume":"13","author":"Llorca","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1034\/j.1399-5618.2003.00048.x","article-title":"Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder","volume":"5","author":"MacQueen","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/YIC.0b013e328343ba60","article-title":"Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features: a prospective study of 3-year outcomes","volume":"26","author":"Malempati","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.10.035_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2008.10.023","article-title":"Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study","volume":"116","author":"Martino","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1399-5618.2010.00865.x","article-title":"Development of the QoL.BD: a disorder-specific scale to assess quality of life in bipolar disorder","volume":"12","author":"Michalak","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib26","first-page":"89","article-title":"Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning","volume":"7","author":"Montes","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jad.2017.10.035_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.jad.2017.10.035_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.schres.2015.07.007","article-title":"Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia","volume":"168","author":"Naber","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2017.10.035_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0447.2006.00982.x","article-title":"The case for long-acting antipsychotic agents in the post-CATIE era","volume":"115","author":"Nasrallah","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2017.10.035_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4088\/JCP.09m05514yel","article-title":"Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study","volume":"71","author":"Perlis","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","article-title":"Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder","volume":"68","author":"Quiroz","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib32","series-title":"Risperidone Long-acting Injection","author":"RISPERDAL\u00ae CONSTA\u00ae","year":"2016"},{"key":"10.1016\/j.jad.2017.10.035_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-5618.2009.00698.x","article-title":"Clinical predictors of functional outcome of bipolar patients in remission","volume":"11","author":"Rosa","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2017.10.035_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1192\/bjp.bp.109.076489","article-title":"Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders","volume":"197","author":"Saarni","year":"2010","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.jad.2017.10.035_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-5618.2006.00314.x","article-title":"Treatment adherence with antipsychotic medications in bipolar disorder","volume":"8","author":"Sajatovic","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.10.035_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/acps.12065","article-title":"Mood instability and functional recovery in bipolar disorders","volume":"128","author":"Strejilevich","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2017.10.035_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jad.2007.12.234","article-title":"Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up","volume":"109","author":"Tabares-Seisdedos","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib40","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.160.12.2099","article-title":"The McLean-Harvard first-episode mania study: prediction of recovery and first recurrence","volume":"160","author":"Tohen","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1176\/appi.ajp.157.2.220","article-title":"Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features","volume":"157","author":"Tohen","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib42","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.4088\/JCP.14m09548","article-title":"Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder","volume":"76","author":"van der Voort","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.7090su1cj","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.10.035_bib44","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1185\/03007991003779380","article-title":"Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium\/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study","volume":"26","author":"Vieta","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2017.10.035_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-5618.2009.00665.x","article-title":"Neurocognitive impairment in bipolar disorder patients: functional implications","volume":"11","author":"Wingo","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hup.1240","article-title":"Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial","volume":"26","author":"Woo","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.10.035_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jad.2012.11.042","article-title":"Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode","volume":"147","author":"Yatham","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.10.035_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry Suppl."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717316270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717316270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:27:06Z","timestamp":1759022826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717316270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":49,"alternative-id":["S0165032717316270"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.10.035","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}